Literature DB >> 8349328

Elevated renovascular tone in young spontaneously hypertensive rats. Role of cytochrome P-450.

J D Imig1, J R Falck, D Gebremedhin, D R Harder, R J Roman.   

Abstract

The present study examined the role of cytochrome P-450 metabolites of arachidonic acid in elevating renal vascular resistance in young spontaneously hypertensive rats (SHR). Differences in vascular tone were assessed in the preglomerular vasculature of 3- to 4-week-old prehypertensive SHR (n = 11) and normotensive Wistar-Kyoto (WKY, n = 10) and Wistar-Lewis (n = 10) rats. Pressure-diameter relations to changes in renal perfusion pressure were compared using the juxtamedullary nephron microvascular preparation perfused in vitro with a physiological salt solution. At a pressure of 60 mm Hg, the basal diameters of the interlobular arteries and proximal and distal afferent arterioles of the SHR averaged 43 +/- 2, 17 +/- 0.3, and 11 +/- 0.4 microns, respectively. The diameters of the interlobular arteries and afferent arterioles were 9% to 14% smaller than those of corresponding vessels in WKY and Wistar-Lewis rats. Addition of P-450 inhibitors, ketoconazole (100 mumol/L) or 7-ethoxyresorufin (1 mumol/L), to the perfusate dilated the afferent arteriole of SHR by 7% to 12%, whereas it increased the diameter by only 0% to 6% in control rats and significantly reduced the differences in the pressure-diameter relation in the preglomerular vasculature of SHR and control rats. Inhibitors of P-450 eliminated the contractile response of afferent arterioles to increases in renal perfusion pressure in all three groups. Removal of calcium from the perfusate eliminated differences in the diameters of the preglomerular vasculature in SHR and normotensive rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349328     DOI: 10.1161/01.hyp.22.3.357

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  23 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 2.  Conflicting roles of 20-HETE in hypertension and renal end organ damage.

Authors:  Chao Zhang; George W Booz; Qing Yu; Xiaochen He; Shaoxun Wang; Fan Fan
Journal:  Eur J Pharmacol       Date:  2018-06-07       Impact factor: 4.432

Review 3.  Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.

Authors:  Fan Fan; Richard J Roman
Journal:  J Am Soc Nephrol       Date:  2017-07-12       Impact factor: 10.121

Review 4.  The role of 20-HETE in androgen-mediated hypertension.

Authors:  Cheng-Chia Wu; Michal Laniado Schwartzman
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-06-22       Impact factor: 3.072

5.  A Mutation in γ-Adducin Impairs Autoregulation of Renal Blood Flow and Promotes the Development of Kidney Disease.

Authors:  Fan Fan; Aron M Geurts; Mallikarjuna R Pabbidi; Ying Ge; Chao Zhang; Shaoxun Wang; Yedan Liu; Wenjun Gao; Ya Guo; Longyang Li; Xiaochen He; Wenshan Lv; Yoshikazu Muroya; Takashi Hirata; Jeremy Prokop; George W Booz; Howard J Jacob; Richard J Roman
Journal:  J Am Soc Nephrol       Date:  2020-02-06       Impact factor: 10.121

6.  CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent.

Authors:  Komal Sodhi; Cheng-Chia Wu; Jennifer Cheng; Katherine Gotlinger; Kazuyoshi Inoue; Mohan Goli; John R Falck; Nader G Abraham; Michal L Schwartzman
Journal:  Hypertension       Date:  2010-09-13       Impact factor: 10.190

Review 7.  20-HETE and blood pressure regulation: clinical implications.

Authors:  Cheng-Chia Wu; Tanush Gupta; Victor Garcia; Yan Ding; Michal L Schwartzman
Journal:  Cardiol Rev       Date:  2014 Jan-Feb       Impact factor: 2.644

Review 8.  Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function.

Authors:  John D Imig
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-01-17       Impact factor: 3.072

Review 9.  20-HETE: Hypertension and Beyond.

Authors:  Richard J Roman; Fan Fan
Journal:  Hypertension       Date:  2018-05-14       Impact factor: 10.190

10.  Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension.

Authors:  Yiqiang Zhou; Pengcheng Luo; Hsin-Hsin Chang; Hui Huang; Tianxin Yang; Zheng Dong; Cong-Yi Wang; Mong-Heng Wang
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.